QMoat Research

    Quick Takes

    Quality-investing analysis, company research and long-term investment insights in Quick Takes.

    Marvell Leans Into AI Boom With Strong Quarter and Bold Bet on Optics
    Quick Takes

    Marvell Leans Into AI Boom With Strong Quarter and Bold Bet on Optics

    Marvell Technology is riding the AI infrastructure wave harder than ever – and placing a fresh wager that the next leg of growth will be optical, not copper.

    Nvidia’s $2 Billion Synopsys Bet Aims to Rewire How Chips Are Designed
    Quick Takes

    Nvidia’s $2 Billion Synopsys Bet Aims to Rewire How Chips Are Designed

    Nvidia’s $2 billion tie-up with Synopsys pulls the chip giant upstream into the tools that design tomorrow’s semiconductors. By fusing Synopsys’ EDA software with Nvidia’s AI hardware, both aim to accelerate chip development—and tighten Nvidia’s grip on the AI ecosystem.

    Straumann pivots from premium hardware to a connected care platform
    Quick Takes

    Straumann pivots from premium hardware to a connected care platform

    Straumann pivots from premium hardware to a connected care platform Straumann’s latest investor day sharpened a narrative that has been building for several years: the Swiss group is evolving from a premium implant maker into an integrated, software‑enabled oral care platform spanning implants, clear aligners and digital workflows.

    Intel's Q3: A Fragile Comeback Gains Momentum
    Quick Takes

    Intel's Q3: A Fragile Comeback Gains Momentum

    Intel’s third quarter showed a company slowly regaining its footing. Revenue ticked up, margins improved, and its foundry ambitions took shape—yet persistent losses and execution risks remind investors that this comeback, while real, remains fragile.

    SGS Q3 Results Show Steady Growth as CEO Géraldine Picaud Delivers on Promises
    Quick Takes

    SGS Q3 Results Show Steady Growth as CEO Géraldine Picaud Delivers on Promises

    SGS’s third-quarter update brings solid organic growth, firmer margins and disciplined M&A execution—early proof that new CEO Géraldine Picaud’s “Strategy 27” is starting to deliver exactly what she promised.

    What’s Going On at Novo Nordisk’s Board?
    Quick Takes

    What’s Going On at Novo Nordisk’s Board?

    Novo Nordisk faces rare boardroom turmoil as its controlling foundation pushes for a sweeping overhaul. Chair Helge Lund and six directors are set to be replaced by a new slate led by ex-CEO Lars Rebien Sørensen—signaling a sharper, U.S.-focused pivot in the obesity-drug race.

    EssilorLuxottica’s Q3: How AI Will Deepend the Moat
    Quick Takes

    EssilorLuxottica’s Q3: How AI Will Deepend the Moat

    EssilorLuxottica’s best quarter since the merger shows momentum is real. Smart glasses, premium lenses, and a thriving retail engine turned Q3 into a breakthrough—suggesting the eyewear giant’s tech-infused growth story is just getting started.

    Infosys’s Q3: AI Is Good for IT Consultants - Just Not the Way You Think
    Quick Takes

    Infosys’s Q3: AI Is Good for IT Consultants - Just Not the Way You Think

    Infosys’s latest quarter offers a sober answer to the hype: AI is good for IT consultants—but the payoff shows up first in bookings, delivery speed and margins, not a top-line sprint.

    ASML's Q3 Update - The Moat holds
    Quick Takes

    ASML's Q3 Update - The Moat holds

    ASML’s Q3 missed on revenue but beat on EBIT, with €5.4 billion in bookings and standout EUV orders. Guidance lifts Q4 above models and keeps 2025 on a ~15% growth track—while 2026 is “not below” 2025.

    Instant Money, Instant Pressure: What Pix and Its Peers Mean for Visa and Mastercard
    Quick Takes

    Instant Money, Instant Pressure: What Pix and Its Peers Mean for Visa and Mastercard

    Brazil’s Pix has turned paying into a tap-and-go habit—and it’s just one sign of a global shift. From India’s UPI to Europe’s new instant-payments law, real-time bank transfers are eroding the turf once dominated by Cards.

    Givaudan 9-Month Update
    Quick Takes

    Givaudan 9-Month Update

    Givaudan’s nine-month update shows resilient organic growth and pricing power, outpacing peers like Symrise. While FX drags and tariffs weigh, Fine Fragrance and beauty actives keep momentum strong as FMCG giants from Nestlé to Pepsi battle volume fatigue.

    Germany’s Quiet Outperformers: Five Small & Mid-Cap Hidden Champions
    Quick Takes

    Germany’s Quiet Outperformers: Five Small & Mid-Cap Hidden Champions

    Germany’s best-kept winners aren’t household names—they’re the makers of crystal growers, bonders, optics and machine-vision gear that let AI and automation leave the lab.

    ASM’s Atomic Playbook: Investor Day Maps €5.7bn Path on ALD, Epi and Services
    Quick Takes

    ASM’s Atomic Playbook: Investor Day Maps €5.7bn Path on ALD, Epi and Services

    ASM set a 2030 course—>€5.7bn revenue, 30% margins—built on ALD dominance, growing epi, outcome-based services and sustainability that lowers customers’ total costs.

    Alcon (ALC) CEO Davis Endicott provides update at Baird Event
    Quick Takes

    Alcon (ALC) CEO Davis Endicott provides update at Baird Event

    At a Baird investor event, Alcon CEO David Endicott framed the next 24–36 months as “dynamic” but messy: seven launches in flight, five acquisitions in ~18 months, and a full-fleet refresh anchored by the new Unity platform.

    Align (ALGN) Technology’s Clear Path Hits a Rough Patch
    Quick Takes

    Align (ALGN) Technology’s Clear Path Hits a Rough Patch

    Align Technology Inc., the maker of Invisalign clear aligners, stunned investors late Wednesday after it lowered its full-year outlook and unveiled a restructuring that includes layoffs and factory write-downs.

    Schindler (SCHP): H1 25 quick take
    Quick Takes

    Schindler (SCHP): H1 25 quick take

    Schindler’s self‑help program is delivering

    Nestlé’s 9M 2025: Tough medicine, clearer diagnosis
    Quick Takes

    Nestlé’s 9M 2025: Tough medicine, clearer diagnosis

    Nestlé’s new CEO is taking tough action: 16,000 job cuts, sharper portfolio focus, and a push for RIG-led growth—real demand, not just pricing. After years of inflation-driven gains, the world’s biggest food group is betting on leaner operations and genuine volume recovery.

    Barry Callebaut (BARN) trims outlook as cocoa volatility weighs on volumes
    Quick Takes

    Barry Callebaut (BARN) trims outlook as cocoa volatility weighs on volumes

    Swiss chocolatier Barry Callebaut (BARN) reported its third revision to full-year volume expectations, citing extreme volatility in cocoa prices, as unveiled in its nine‑month results today. The company now anticipates a 7 % drop in sales volume by Aug.

    US rolls back EDA export curbs—opening the door for Synopsys (SNPS) and Cadence (CDNS)
    Quick Takes

    US rolls back EDA export curbs—opening the door for Synopsys (SNPS) and Cadence (CDNS)

    The U.S. Commerce Department has rescinded the licence letters it sent in late May that forced America’s three big electronic-design-automation vendors—Synopsys, Cadence Design Systems and Siemens EDA—to halt most sales and support for Chinese chip designers.

    MU: Micron Q3 Earnings Call and the AI Era Strategy Briefing
    Quick Takes

    MU: Micron Q3 Earnings Call and the AI Era Strategy Briefing

    Micron’s latest earnings call felt less like a numbers parade and more like a playbook for securing pole‑position in the artificial‑intelligence supply chain.